Monthly Archives: May 2026
-
May 18, 2026
We've compared both of these compounds with RAD-140 before, but never with each other. That's a notable gap, because Ostarine (MK-2866) and LGD-4033 (Ligandrol) are probably the two most talked-about SARMs, and they are also the two with the most human research data.
Both are non-steroidal selective androgen receptor modulators. Both have been through human trials. Both come up regularly in lean-mass research. They differ mainly in potency, how far development went, and the kinds of research questions each is usually linked to.
All information is for educational and research purposes only.
Ostarine (MK-2866) — The Most Clinically Studied SARM
Ostarine, also called enobosarm or GTx-024, was developed by GTx Inc. It binds to the androgen receptor with high selectivity for muscle and bone. It was designed to have much less effect on tissues such as the prostate and skin.
Few SARMs have been through as
